T + A方案改善免疫微环境,实现晚期HCC优质生存Bevacizumab plus AtezolizumabImprove the Immune Microenvironment and Achieve High Quality Survival of Advanced in HCC
阿力亚·买买提吐尔逊, 张 韬 下载量: 285 浏览量: 364
临床医学进展 Vol.13 No.3, March 30 2023, PDF, HTML, XML DOI:10.12677/ACM.2023.133695 被引量
以免疫抑制剂为基础的全身系统治疗在晚期肝细胞癌的应用及研究进展Application and Research Progress of Immunosuppressive Agent-Based Systemic System Therapy in Advanced Hepatocellular Carcinoma
范晨晶, 姬发祥 下载量: 258 浏览量: 326
临床医学进展 Vol.12 No.4, April 22 2022, PDF, HTML, XML DOI:10.12677/ACM.2022.124444 被引量
基于肝动脉灌注化疗的肝细胞癌治疗进展Progress in the Treatment of Hepatocellular Carcinoma Based on Hepatic Arterial Infusion Chemotherapy
郭 宇, 刘作金 下载量: 378 浏览量: 580
临床医学进展 Vol.12 No.1, January 26 2022, PDF, HTML, XML DOI:10.12677/ACM.2022.121087 被引量
肝细胞癌分级与动脉血供的相关性研究The Relationship between the Grade of Hepatocellular Carcinoma and Arterial Blood Supply
李淑文, 王海久 下载量: 48 浏览量: 129
临床个性化医学 Vol.3 No.1, March 29 2024, PDF, HTML, XML DOI:10.12677/jcpm.2024.31020 被引量
肝癌的分子治疗Molecular Therapy of Liver Cancer
孟永昌, 董明明, 闫 军 下载量: 213 浏览量: 274
临床医学进展 Vol.13 No.5, May 17 2023, PDF, HTML, XML DOI:10.12677/ACM.2023.1351100 被引量
TACE联合TIPS治疗肝癌合并门脉高压有效性和安全性的META分析Efficacy and Safety of TACE Combined with TIPS in the Treatment of Hepatocellular Carcinoma Complicated with Portal Hypertension: A Meta-Analysis
李俊池, 汪宏翔, 徐 颖, 杨 慷 下载量: 98 浏览量: 128
临床医学进展 Vol.14 No.2, February 28 2024, PDF, HTML, XML DOI:10.12677/ACM.2024.142535 被引量
TACE联合靶向治疗药物治疗中晚期肝癌的临床疗效的Meta分析Meta-Analysis on the Clinical Efficacy of Transcatheter Arterial Chemoembolization Combined with Targeted Therapy in the Treatment of Middle and Advanced Liver Cancer
向 康, 戴鑫杰, 李 丹, 吴登鼎, 杨新宇, 艾 空, 胡 军 下载量: 115 浏览量: 175 科研立项经费支持
临床医学进展 Vol.14 No.1, January 31 2024, PDF, HTML, XML DOI:10.12677/ACM.2024.141307 被引量